Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

1,248 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
MPS1 inhibition primes immunogenicity of KRAS-LKB1 mutant lung cancer.
Kitajima S, Tani T, Springer BF, Campisi M, Osaki T, Haratani K, Chen M, Knelson EH, Mahadevan NR, Ritter J, Yoshida R, Köhler J, Ogino A, Nozawa RS, Sundararaman SK, Thai TC, Homme M, Piel B, Kivlehan S, Obua BN, Purcell C, Yajima M, Barbie TU, Lizotte PH, Jänne PA, Paweletz CP, Gokhale PC, Barbie DA. Kitajima S, et al. Among authors: tani t. Cancer Cell. 2022 Sep 18:S1535-6108(22)00379-8. doi: 10.1016/j.ccell.2022.08.015. Online ahead of print. Cancer Cell. 2022. PMID: 36150391
MET-induced CD73 restrains STING-mediated immunogenicity of EGFR-mutant lung cancer.
Yoshida R, Saigi M, Tani T, Springer BF, Shibata H, Kitajima S, Mahadevan NR, Campisi M, Kim W, Kobayashi Y, Thai TC, Haratani K, Yamamoto Y, Sundararaman SK, Knelson EH, Vajdi A, Canadas I, Uppaluri R, Paweletz CP, Miret JJ, Lizotte PH, Gokhale PC, Janne PA, Barbie DA. Yoshida R, et al. Among authors: tani t. Cancer Res. 2022 Sep 6:CAN-22-0770. doi: 10.1158/0008-5472.CAN-22-0770. Online ahead of print. Cancer Res. 2022. PMID: 36066413
1,248 results